Drug Patent List
Oppositions
Newsletter
Weekly Digest

Pharsight

Daptomycin Patent Expiration

Daptomycin was first introduced by Cubist Pharmaceuticals Llc in its drug Cubicin on Sep 12, 2003. Other drugs containing Daptomycin are Daptomycin In 0.9% Sodium Chloride, Daptomycin, Dapzura Rt, Cubicin Rf. 20 different companies have introduced drugs containing Daptomycin.


Daptomycin Patents

Given below is the list of patents protecting Daptomycin, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Cubicin US6468967 Methods for administration of antibiotics Sep 24, 2019

(Expired)

 Cubist Pharms Llc
Cubicin US6852689 Methods for administration of antibiotics Sep 24, 2019

(Expired)

 Cubist Pharms Llc
Cubicin US8003673 Daptomycin for the treatment of biofilm and catheter salvage Sep 04, 2028 Cubist Pharms Llc
Cubicin US8058238 High purity lipopeptides Nov 28, 2020

(Expired)

 Cubist Pharms Llc
Cubicin US8129342 High purity lipopeptides Nov 28, 2020

(Expired)

 Cubist Pharms Llc
Cubicin US9138456 Lipopeptide compositions and related methods Nov 23, 2030 Cubist Pharms Llc
Cubicin USRE39071 Anhydro-and isomer-a-21978c cyclic peptides Jun 15, 2016

(Expired)

 Cubist Pharms Llc
Cubicin Rf US9138456 Lipopeptide compositions and related methods Nov 23, 2030 Cubist Pharms Llc
Daptomycin US10357535 Daptomycin formulations and uses thereof Sep 11, 2033 Hospira
Daptomycin US11759497 Daptomycin formulations Aug 28, 2038 Xellia Pharms Aps
Daptomycin US9655946 Daptomycin formulations and uses thereof Sep 11, 2033 Hospira
Dapzura Rt US11173189 Daptomycin formulations containing a combination of sorbitol and mannitol Mar 11, 2041 Baxter Hlthcare Corp


A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Daptomycin's patents.

Given below is the list recent legal activities going on the following patents of Daptomycin.

Event Date Patent/Publication
Patent litigations
Email Notification 20 Sep, 2023 US11759497
Recordation of Patent eGrant 19 Sep, 2023 US11759497
Patent eGrant Notification 19 Sep, 2023 US11759497
Recordation of Patent Grant Mailed 19 Sep, 2023 US11759497
Patent Issue Date Used in PTA Calculation 19 Sep, 2023 US11759497
Mail Patent eGrant Notification 19 Sep, 2023 US11759497
Email Notification 01 Sep, 2023 US11759497
Issue Notification Mailed 30 Aug, 2023 US11759497
Dispatch to FDC 09 Aug, 2023 US11759497
Application Is Considered Ready for Issue 09 Aug, 2023 US11759497



Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳

Daptomycin Generics

Several generic applications have been filed for Daptomycin. The first generic version for Daptomycin was by Hospira Inc and was approved on Sep 12, 2014. And the latest generic version is by Mylan Pharmaceuticals Inc A Viatris Co and was approved on Aug 7, 2023.

Given below is the list of companies who have filed for Daptomycin generic.


1. XELLIA PHARMS APS

Xellia Pharmaceuticals Aps has filed for 1 generic for Daptomycin. Given below are the details of the strengths of this generic introduced by Xellia Pharms Aps.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG/VIAL powder Prescription INTRAVENOUS AP Jun 15, 2016


2. ACCORD HLTHCARE

Accord Healthcare Inc has filed for 2 different strengths of generic version for Daptomycin. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG/VIAL powder Prescription INTRAVENOUS AP Jun 24, 2019
350MG/VIAL powder Prescription INTRAVENOUS AP Jul 12, 2019


3. MYLAN LABS LTD

Mylan Laboratories Ltd has filed for 1 generic for Daptomycin. Given below are the details of the strengths of this generic introduced by Mylan Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG/VIAL powder Prescription INTRAVENOUS AP Jun 5, 2018


4. TEVA PHARMS USA

Teva Pharmaceuticals Usa Inc has filed for 1 generic for Daptomycin. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG/VIAL powder Prescription INTRAVENOUS AP Mar 25, 2016


5. DR REDDYS

Dr Reddys Laboratories Ltd has filed for 2 different strengths of generic version for Daptomycin. Given below are the details of the strengths of this generic introduced by Dr Reddys.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG/VIAL powder Prescription INTRAVENOUS AP May 1, 2019
350MG/VIAL powder Prescription INTRAVENOUS AP Aug 31, 2020


6. QILU PHARM HAINAN

Qilu Pharmaceutical Hainan Co Ltd has filed for 1 generic for Daptomycin. Given below are the details of the strengths of this generic introduced by Qilu Pharm Hainan.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG/VIAL

(reference standard)

powder Prescription INTRAVENOUS AP Aug 24, 2021


7. HAINAN POLY PHARM

Hainan Poly Pharmaceutical Co Ltd has filed for 1 generic for Daptomycin. Given below are the details of the strengths of this generic introduced by Hainan Poly Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG/VIAL powder Prescription INTRAVENOUS AP Aug 18, 2022


8. ASPIRO

Aspiro Pharma Ltd has filed for 2 different strengths of generic version for Daptomycin. Given below are the details of the strengths of this generic introduced by Aspiro.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG/VIAL powder Prescription INTRAVENOUS AP Sep 23, 2022
350MG/VIAL powder Prescription INTRAVENOUS AP Dec 23, 2022


9. HANGZHOU ZHONGMEI

Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd has filed for 1 generic for Daptomycin. Given below are the details of the strengths of this generic introduced by Hangzhou Zhongmei.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG/VIAL powder Prescription INTRAVENOUS AP Nov 26, 2021


10. MYLAN

Mylan Pharmaceuticals Inc A Viatris Co has filed for 1 generic for Daptomycin. Given below are the details of the strengths of this generic introduced by Mylan.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG/VIAL powder Prescription INTRAVENOUS AP Aug 7, 2023


11. HOSPIRA

Hospira Inc has filed for 1 generic for Daptomycin. Given below are the details of the strengths of this generic introduced by Hospira.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG/VIAL powder Discontinued INTRAVENOUS N/A Sep 12, 2014


12. BE PHARMS

Be Pharmaceuticals Ag has filed for 2 different strengths of generic version for Daptomycin. Given below are the details of the strengths of this generic introduced by Be Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG/VIAL powder Prescription INTRAVENOUS AP Jun 26, 2019
350MG/VIAL powder Prescription INTRAVENOUS AP Aug 20, 2020


13. HENGRUI PHARMA

Jiangsu Hengrui Pharmaceuticals Co Ltd has filed for 1 generic for Daptomycin. Given below are the details of the strengths of this generic introduced by Hengrui Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG/VIAL powder Prescription INTRAVENOUS AP Aug 22, 2019


14. MEITHEAL

Meitheal Pharmaceuticals Inc has filed for 2 different strengths of generic version for Daptomycin. Given below are the details of the strengths of this generic introduced by Meitheal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
350MG/VIAL powder Prescription INTRAVENOUS AP Jun 29, 2021
500MG/VIAL powder Prescription INTRAVENOUS AP Jun 29, 2021


15. EUGIA PHARMA

Eugia Pharma Specialities Ltd has filed for 1 generic for Daptomycin. Given below are the details of the strengths of this generic introduced by Eugia Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG/VIAL powder Prescription INTRAVENOUS AP Sep 2, 2021


16. HISUN PHARM HANGZHOU

Hisun Pharmaceutical Hangzhou Co Ltd has filed for 1 generic for Daptomycin. Given below are the details of the strengths of this generic introduced by Hisun Pharm Hangzhou.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG/VIAL powder Prescription INTRAVENOUS AP Apr 21, 2021


17. FRESENIUS KABI USA

Fresenius Kabi Usa Llc has filed for 1 generic for Daptomycin. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG/VIAL powder Prescription INTRAVENOUS AP Apr 11, 2018


18. SAGENT PHARMS INC

Sagent Pharmaceuticals Inc has filed for 1 generic for Daptomycin. Given below are the details of the strengths of this generic introduced by Sagent Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
500MG/VIAL powder Prescription INTRAVENOUS AP Nov 15, 2019